This Week on StackScout

Salesforce CPQ End of Sale: The RevOps Migration Playbook — Salesforce CPQ is end of sale and the migration backlog at major SIs is already 6–12 months deep. A complete decision framework for RevOps directors: how to assess your current state, which platform pathways make sense, and how to execute a zero-downtime transition.

Agentic AI in CPQ: The 2026 Shift RevOps Leaders Can't Ignore — Autonomous quote-to-cash workflows are moving from vendor demo to production deployment in 2026. A guide to what's genuinely new, what's marketing noise, and the evaluation framework that separates production-ready from pilot-only.

Zuora AI Is Here: Is Your Implementation Ready? — Zuora is shipping AI fast, but most implementations aren't ready to use it. A practical readiness checklist covering data quality, integration prerequisites, and the five gaps Zuora won't tell you about.

The Algorithmic Collusion Risk: Why Your AI Pricing Bot Could Trigger Antitrust Issues — Regulators in the US, EU, and UK have opened investigations into AI dynamic pricing. The risk framework, audit requirements, and responsible-AI guardrails every CFO and General Counsel needs.

Multi-CRM CPQ Orchestration: The Architecture Guide No Vendor Will Give You — The average enterprise runs 3.4 CRMs. A practical architecture guide for CPQ orchestration across multiple CRM environments: topology options, integration patterns, data governance, and the tradeoffs vendors never explain.

Claude Fable 5 Enterprise Buyer Guide: What IT Leaders Need to Know Before Upgrading — 80.3% on SWE-bench Pro vs GPT-5.5's 58.6%, but 2x the token cost and a safety routing layer that silently falls back ~5% of sessions. Real pricing math, benchmark breakdowns, and a clear upgrade decision framework.

Tech Radar

• SpaceX IPO Opens at $150/share: Becomes the world's 6th most valuable public company at >$2 trillion market cap, with Elon Musk approaching trillionaire status (The Verge)
• AI IPO Summer — MANGOS: Meta, Anthropic, Nvidia, Google, OpenAI, and SpaceX now lead the IPO market as major AI companies go public simultaneously (TechCrunch)
• CRISPR Selectively Shreds Cancer Cells: Gene editing breakthrough shows promise against "undruggable" cancers previously untreatable with existing therapies (Innovative Genomics)

STR Spotlight

908 Nueces St Unit 37 in downtown Austin (78701) stands out this week: $415K purchase price, 20.51% cap rate, 69.80% cash-on-cash return, and $138K projected annual revenue at 70% occupancy — verify Austin STR permit and building CC&Rs before any offer.

You're receiving this because you subscribed at stackscout.co. Unsubscribe anytime.